Rockwell Medical targets $1M–$2M adjusted EBITDA and positive cash flow in 2026 as product mix diversifies (NASDAQ:RMTI)
Rockwell MedicalRockwell Medical(US:RMTI) Seeking Alpha·2026-03-26 22:46

新闻内容技术访问问题 - 用户浏览器设置可能阻碍了新闻内容的正常加载 为确保未来能正常访问 需在浏览器中启用Javascript和cookies [1] - 如果用户启用了广告拦截器 可能会被阻止继续访问 需要禁用广告拦截器并刷新页面 [1]

Rockwell Medical targets $1M–$2M adjusted EBITDA and positive cash flow in 2026 as product mix diversifies (NASDAQ:RMTI) - Reportify